Literature DB >> 27074842

[Is consolidative radiotherapy needed after chemotherapy in early stage diffuse large B‑cell lymphoma?].

Carsten Nieder1.   

Abstract

Mesh:

Year:  2016        PMID: 27074842     DOI: 10.1007/s00066-016-0967-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Combined-Modality Therapy for Early-Stage Diffuse Large B-Cell Lymphoma: Knowing When to Quit.

Authors:  Dan L Longo
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

Review 2.  Treatment approach to newly diagnosed diffuse large B-cell lymphoma.

Authors:  Emmanuel Bachy; Gilles Salles
Journal:  Semin Hematol       Date:  2015-01-15       Impact factor: 3.851

Review 3.  Novel targeted therapies in diffuse large B-cell lymphoma.

Authors:  Neha Mehta-Shah; Anas Younes
Journal:  Semin Hematol       Date:  2015-01-19       Impact factor: 3.851

4.  Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

Authors:  Hervé Ghesquieres; Susan L Slager; Fabrice Jardin; Amelie S Veron; Yan W Asmann; Matthew J Maurer; Thierry Fest; Thomas M Habermann; Marie C Bene; Anne J Novak; Sylvain Mareschal; Corinne Haioun; Thierry Lamy; Stephen M Ansell; Herve Tilly; Thomas E Witzig; George J Weiner; Andrew L Feldman; Ahmet Dogan; Julie M Cunningham; Curtis L Olswold; Thierry Jo Molina; Brian K Link; Noel Milpied; David G Cox; Gilles A Salles; James R Cerhan
Journal:  J Clin Oncol       Date:  2015-10-12       Impact factor: 44.544

Review 5.  The genetic landscape of diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

6.  Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?

Authors:  John A Vargo; Beant S Gill; Goundappa K Balasubramani; Sushil Beriwal
Journal:  J Clin Oncol       Date:  2015-08-10       Impact factor: 44.544

7.  Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.

Authors:  Matthew J Maurer; Jean-Philippe Jais; Hervé Ghesquières; Thomas E Witzig; Fangxin Hong; Corinne Haioun; Carrie A Thompson; Catherine Thieblemont; Ivana N Micallef; Luis F Porrata; Vincent Ribrag; Gregorz S Nowakowski; Olivier Casasnovas; Serge Bologna; Franck Morschhauser; Vicki A Morrison; Bruce A Peterson; William R Macon; Christiane Copie-Bergman; Andrew L Feldman; Sergei I Syrbu; Paul J Kurtin; Randy D Gascoyne; Hailun Li; Cristine Allmer; Brad S Kahl; Stephen M Ansell; Susan L Slager; Brian K Link; Gilles Salles; Thomas M Habermann; Hervé Tilly; James R Cerhan
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

  7 in total
  1 in total

Review 1.  Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy.

Authors:  Omar Habibeh; Khaled Elsayad; Jan Kriz; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.